News

Why American Eagle Outfitters Rallied in August

Key PointsPresident Trump gave the thumbs-up to Sydney Sweeney's controversial ad campaign. American Eagle also announced a collaboration with Travis Kelce, one day after the anno

Source  The Motley Fool1757263500
Survey: Social Security Cuts Would Be Unmanageable for Over 60% of Recipients

Key PointsMost retirees couldn't cope with a big Social Security cut. Cuts are a looming threat, but most people won't see them right away.Retirees should start saving for a rainy

Source  The Motley Fool1757263140
These Were the 5 Top-Performing Stocks in the Dow Jones Industrial Average in August 2025

Key PointsWarren Buffett made key moves out of Apple and into UnitedHealth.Amazon's multiple revenue streams are paying off handsomely.American Express and Home Depot have kept the

Source  The Motley Fool1757262600
SWIFT & Ripple (XRP): Frenemies or Just Foes?

Key PointsMultiple crypto news sources reported SWIFT would test XRP and Hedera tokens in November, but no official SWIFT announcements confirm these trials.November marks the dead

Source  The Motley Fool1757261220
Prediction: Joby Aviation Will Crush the Market in 2026. Here's Why.

Key PointsThe eVTOL market could be worth $9 trillion by 2050, and Joby is poised to capture a large chunk of that. It's in stage four of an FAA certification -- the next-to-last s

Source  The Motley Fool1757260500
1 Reason Every Investor Should Know About Lululemon (LULU)

Key PointsLululemon shares trade significantly below their peak from December 2023. Value investors might start to take a closer look at the beaten-down stock. It's easy to forget

Source  The Motley Fool1757259780
Motley Fool CEO Warns Unchecked AI Could Push "Civilization One Direction or Another"

Key PointsThe rapid spread of AI may make it impossible to regulate.Its far-reaching effects will spread to every corner of society.Investors should exercise both caution and patie

Source  The Motley Fool1757259720
The Trade Desk Stock: Why I'd Wait for a Better Entry Point Before Buying

Key PointsThe Trade Desk's revenue growth rate has been slowing.Big-tech rivals with aggressive ambitions in advertising could challenge The Trade Desk stock's premium valuation.St

Source  The Motley Fool1757259660
3 Ways Airbnb Can Sustain Its Growth Engines

Key PointsLonger stays now account for nearly 1 in 5 bookings.International expansion offers a massive addressable market.Airbnb is building a broader travel ecosystem.10 stocks we

Source  The Motley Fool1757259420
Is Broadcom the Next Nvidia, Offering Investors Life-Changing Returns?

Key PointsBroadcom is benefiting from AI demand and VMware's software cash engine, but it's not playing the same game as Nvidia.After the post-earnings jump, expectations are high.

Source  The Motley Fool1757259360
Lululemon Stock Has Been Absolutely Demolished. Time to Buy?

Key PointsThe stock's sell-off reflects a reset in expectations, not a broken business.Management revised its outlook lower, citing tariff costs and softer U.S. demand, while inter

Source  The Motley Fool1757259060
A Little Good News for Ford and GM

Key PointsDemand for EVs came pouring in with the end of the $7,500 tax credit looming.Ford posted its sixth consecutive month of sales gains in the U.S.General Motors has emerged

Source  The Motley Fool1757258640
1 Incredible Reason to Buy This Dividend Stock Before Oct. 14

Key PointsMany of the tariffs imposed by the U.S. government might come to an abrupt halt on that date.Retailers have been negatively affected by the levies, and Target is no excep

Source  The Motley Fool1757258280
Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time.

Key PointsViking Therapeutics stock took a hit due to disappointing tolerability data in a phase 2 trial. The company still has strategic options, and it may attract the interest o

Source  The Motley Fool1757258040
Buy This, Not That: The Hazards Are Flashing for 1 EV Maker

Key PointsA fourth-quarter lull in demand for the EV industry could spell buying opportunity for investors.Rivian is well positioned to thrive in 2026 with the R2 launch.VinFast's

Source  The Motley Fool1757257920
Billionaires David Tepper and Dan Loeb Are Piling Into This AI Giant That's Soared 1,100% Over 3 Years. Should You Follow?

Key PointsTepper and Loeb increased their positions in this AI company by more than 400% and 90%, respectively, in the second quarter.The two investors clearly think this stock has

Source  The Motley Fool1757257800
The Ultimate Growth Stock to Buy With $1,000 Now

Key PointsDeckers tumbled earlier this year, but the company is still delivering solid growth.It now trades at a substantial discount to the S&P 500.The company expects to take a $

Source  The Motley Fool1757257560
Prediction: This Undervalued Artificial Intelligence (AI) Stock Will Be Worth $5 Trillion by 2030

Key PointsAlphabet's AI prowess has dramatically improved.Google Cloud is seeing huge demand for external AI workloads.The stock trades at a steep discount to its peers. 10 stocks

Source  The Motley Fool1757257500
Looking to Build Wealth Without Lifting a Finger? Your 401(k) Match Can Do the Work.

Key PointsMost 401(k) matches are somewhere between 3% and 6% of your annual income.You can only claim your 401(k) match by deferring a portion of your paychecks.There's still time

Source  The Motley Fool1757257200
Where Will Apple Stock Be in 3 Years?

Key PointsApple has underperformed the S&P 500 over the past three years.It struggled with slowing iPhone sales, tariffs, and other macro challenges.But its business is stabilizing

Source  The Motley Fool1757257200
This Stock Could Pay Off Better Than a Lottery Ticket -- if You Hold Long Enough

Key PointsSentinelOne crossed $1 billion in annual recurring revenue and maintains an industry-leading gross margin.The cybersecurity company is expanding from endpoint security in

Source  The Motley Fool1757256300
Prediction: Oklo Stock Will Be Worth This Much 1 Year From Now

Key PointsAs AI applications grow more complex, the energy needs to power them are becoming more demanding.Nuclear energy has emerged as a compelling alternative energy compared to

Source  The Motley Fool1757255400
Is SoundHound AI Stock a Buy Now?

Key PointsAcquisitions have helped expand its business into more industries, such as restaurants and healthcare.When Nvidia sold its holdings in the company earlier this year, Soun

Source  The Motley Fool1757254500
1 Reason Every Investor Should Know About PayPal (PYPL)

Key PointsPayPal shares trade at an alarming 77% below their peak. The stock can be purchased at a huge discount to the overall market. There are numerous reasons to think this is

Source  The Motley Fool1757253600
Should You Choose a Roth IRA Over a 401(k) for Retirement Savings?

Key PointsMoney in a Roth IRA can be withdrawn tax-free after you reach retirement age.The 401(k) has a much higher contribution limit, and often an employer match.The $23,760 Soci

Source  The Motley Fool1757252700
Where Will Bitcoin Be in 5 Years?

Key PointsBitcoin's value has soared nearly 1,000% over the past five years.The cryptocurrency is growing in legitimacy thanks to institutional adoption and the launch of Bitcoin E

Source  The Motley Fool1757252580
Is Pfizer a Millionaire Maker?

Key PointsPfizer is one of the world's largest and oldest drug companies.Thanks to its Covid vaccine, shares rose dramatically during the pandemic.Now that the stock has sharply co

Source  The Motley Fool1757251800
2 Beaten-Down Stocks to Buy on the Dip

Key PointsIntuitive Surgical's dominance in its niche should allow it to overcome tariffs and increased competition. Regeneron Pharmaceuticals is relying on its innovative capabili

Source  The Motley Fool1757250900
Prediction: These Could Be the Next Tech Multibagger Stocks

Key PointsMicron’s stock stands to benefit from booming HBM demand, stronger guidance, and a cheap valuation. TSMC’s dominance in advanced nodes and packaging makes it a crucial su

Source  The Motley Fool1757250000
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts

Key PointsPrecigen stock soared on news that its first drug earned approval.Mineralys is a pre-commercial biotech with a hypertension candidate in late-stage testing.AstraZeneca ha

Source  The Motley Fool1757247780
goTop
quote